XML 12 R2.htm IDEA: XBRL DOCUMENT v3.24.3
Consolidated Balance Sheets - USD ($)
$ in Millions
Sep. 30, 2024
Dec. 31, 2023
Current assets:    
Cash and cash equivalents $ 3,319 $ 3,226
Accounts receivables, net of allowance for credit losses of $91 million and $95 million as of September 30, 2024 and December 31, 2023 3,462 3,408
Inventories 3,959 4,021
Prepaid expenses 1,127 1,255
Other current assets 445 504
Assets held for sale 2 70
Total current assets 12,314 12,485
Deferred income taxes 2,070 1,812
Other non-current assets 459 470
Property, plant and equipment, net 5,672 5,750
Operating lease right-of-use assets, net 364 397
Identifiable intangible assets, net 4,756 5,387
Goodwill 16,124 [1] 17,177
Total assets 41,758 43,479
Current liabilities:    
Short-term debt 2,580 1,672
Sales reserves and allowances 3,785 3,535
Accounts payables 2,371 2,602
Employee-related obligations 619 611
Accrued expenses 2,984 2,771
Other current liabilities 1,241 1,044
Liabilities held for sale 216 13
Total current liabilities 13,797 12,247
Long-term liabilities:    
Deferred income taxes 538 606
Other taxes and long-term liabilities 4,344 4,019
Senior notes and loans 16,400 18,161
Operating lease liabilities 295 320
Total long-term liabilities 21,578 23,106
Commitments and contingencies, see note 10
Total liabilities 35,375 35,353
Teva shareholders' equity:    
Ordinary shares of NIS 0.10 par value per share; September 30, 2024 and December 31, 2023: authorized 2,495 million shares; issued 1,240 million shares and 1,227 million shares, respectively 58 57
Additional paid-in capital 27,860 27,807
Accumulated deficit (14,956) (13,534)
Accumulated other comprehensive loss (2,769) (2,697)
Treasury shares as of September 30, 2024 and December 31, 2023: 106 million ordinary shares (4,128) (4,128)
Stockholders' equity attributable to Teva shareholders 6,065 7,506
Non-controlling interests 319 620
Total equity 6,383 8,126
Total liabilities and equity $ 41,758 $ 43,479
[1] Cumulative goodwill impairment as of September 30, 2024 and December 31, 2023 was approximately $29.0 billion and $28.3 billion, respectively.